Seroprevalence of IgG Antibodies Against Toxoplasma gondii in HIV-Infected and Non-Infected Population in Iquitos, Peru
Pathogens · 2026-04-01 · 15 (4) · 374
DOI: 10.3390/pathogens15040374 ↗At a glance
Journal article in Pathogens, published online on 2026-04-01. Written by Margot Faustino and 6 co-authors. Institution: Laboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia (UPCH), Lima 15102, Peru. Major MEDLINE topics: Immunoglobulin G, Toxoplasma, Toxoplasmosis, HIV Infections. 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica.
Abstract (original language)
Toxoplasmosis is a cosmopolitan zoonosis that particularly threatens pregnant women, their fetuses and immunocompromised individuals. Among people living with HIV, Toxoplasma gondii may invade the central nervous system, producing neuropathological effects associated with mental and psychiatric disorders. We assessed the seroprevalence of anti-T. gondii IgG in HIV-infected and HIV-uninfected residents of Iquitos, Peru, and evaluated an in-house ELISA based on total lysate antigen (TLA) and recombinant GRA1 (rGRA1), with ELISA-TLA compared against a commercial kit. In this observational cross-sectional study, 151 participants were enrolled: 92 HIV-positive and 59 HIV-negative. ELISA-TLA showed a seroprevalence of 88.08% (133/151), reaching 91.30% (84/92) in the HIV-positive group and 83.05% (49/59) in the HIV-negative group. ELISA-rGRA1 showed a similar epidemiological pattern but lower overall seroprevalence, 81.46% (123/151), with 84.78% (78/92) in HIV-positive and 74.58% (44/59) in HIV-negative participants. Taken together, both TLA and rGRA1-based ELISAs showed similar epidemiological patterns, supporting the consistency of the serological findings. These results also indicate very high exposure to T. gondii in Iquitos, particularly among HIV-positive individuals, in whom prior exposure is clinically relevant because of the risk of reactivation under immunosuppression. Serological screening and preventive counseling may therefore be warranted in high-burden Amazonian communities.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia (UPCH), Lima 15102, Peru.
- Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Ingeniería, Universidad Peruana Cayetano Heredia (UPCH), Lima 15102, Peru.
- Laboratorio de Parasitología Molecular y Celular, Facultad de Ciencias Bilógicas, Universidad Nacional Mayor de San Marcos (UNMSM), Lima 15081, Peru.
ORCID profiles: Margot Faustino, Carlos Alonso Flores, Edith S Málaga-Machaca, Luis Canales, Juan Jiménez-Chunga, Patricia Sheen, Maritza Calderón
Funding
- Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
Cite
APA
Faustino, M., Flores, C. A., Málaga-Machaca, E. S., Canales, L., Jiménez-Chunga, J., Sheen, P., & Calderón, M. (2026). Seroprevalence of IgG Antibodies Against Toxoplasma gondii in HIV-Infected and Non-Infected Population in Iquitos, Peru. Pathogens, 15(4), 374. https://doi.org/10.3390/pathogens15040374
Vancouver
Faustino M, Flores CA, Málaga-Machaca ES, Canales L, Jiménez-Chunga J, Sheen P, et al. Seroprevalence of IgG Antibodies Against Toxoplasma gondii in HIV-Infected and Non-Infected Population in Iquitos, Peru. Pathogens. 2026;15(4):374. doi:10.3390/pathogens15040374
BibTeX
@article{Faustino2026,
author = {Faustino, Margot and Flores, Carlos Alonso and Málaga-Machaca, Edith S and Canales, Luis and Jiménez-Chunga, Juan and Sheen, Patricia and Calderón, Maritza},
title = {Seroprevalence of IgG Antibodies Against Toxoplasma gondii in HIV-Infected and Non-Infected Population in Iquitos, Peru},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {4},
pages = {374},
doi = {10.3390/pathogens15040374}
}
EUVIMED